-transparent.png){kind=logo}
Somatostatin (SOM) at doses up to 1 microgram was not effective on the motility of canine and guinea pig gallbladder smooth muscle preparations in vitro. When the preparations were contracted by field electrical stimulation (0.7 ms, 40 Hz) the cholecystokinin octapeptide (CCK OP) enhanced these contractions while SOM inhibited them. These effects were accompanied, respectively, by an increase or a decrease in [3H] acetylcholine (ACh) release in the intrinsic cholinergic nerve terminals. SOM (0.5 to 2 micrograms/kg i.v.) inhibited the spontaneous and the CCK OP-activated gallbladder pressure in conscious dogs. The effect of atropine (10-50 micrograms/kg) was similar to that of SOM when injected intravenously in conscious dogs. It is suggested that the inhibitory effect of SOM on gallbladder pressure in conscious dogs is probably mediated by a decrease in ACh release by cholinergic neurons.
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
September 1987,
The British journal of surgery,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
February 1999,
Neurogastroenterology and motility,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
January 1995,
European journal of clinical pharmacology,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
January 1991,
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
October 1993,
Neuropeptides,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
January 1978,
Acta radiologica: diagnosis,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
April 1995,
Gastroenterology,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
January 2001,
Clinical physiology (Oxford, England),
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
June 1993,
Gastroenterology,
K Milenov, and
A Rakovska, and
R Kalfin, and
P Mantovani
July 1997,
Digestive diseases and sciences,
